Vivametrica makes pitch for mHealth data aggregation and analysis market

The market for mHealth data aggregation platforms has become increasingly congested over the past year, with Apple ($AAPL) and Google ($GOOG) joining the more healthcare industry-focused Validic. Now Vivametrica has joined the space, outlining plans for a platform that fixes the inconsistencies in data from consumer mHealth products and combines them with outputs from medical devices.

Vivametrica CEO Dr. Richard Hu

ZDNet reports Vivametrica will enter private beta later this month and hopes to introduce a free, consumer-focused version of its platform in December. The platform will initially pull data from devices such as Fitbit and aggregators such as Google Fit and Apple HealthKit for analysis alongside public health information. By comparing an individual's data with public datasets, Vivametrica thinks it can show users how changing their lifestyle would affect the probability of certain health outcomes.

Research applications for the platform are set to follow the consumer launch, with Vivametrica targeting a mid-2015 introduction date for its paid-for service. Data from medical devices--starting with blood pressure monitors--will also be incorporated into the platform, potentially making it much more useful to physicians and health researchers. Vivametrica also expects to add data from smart contact lenses--which Google is developing with Novartis ($NVS)--and other devices in the future.

"If we have a new sensor and we can bring digital data in, we can add it and analyse it, and if we have enough uptake we have biostatisticians who can derive appropriate algorithms," Vivametrica CEO Dr. Richard Hu said. Of course, an analytics platform is only as good as the data it uses, and as such Vivametrica is taking steps to standardize the somewhat variable output of consumer mHealth devices. Vivametrica has started a seed round to fund the work, VentureBeat reports.

- read ZDNet's article
- here's VentureBeat's take
- and the press release

Suggested Articles

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.

The $58 million financing round represents biopharma industry's growing interest in genomics data.

Clinerion inks a new deal that adds 60 million U.S. patients to its clinical trial patient recruitment system.